Semperit 2022 results to be ‘significantly below market expectations’

Vienna – Semperit Group expects its 2022 annual results to be "significantly below average market expectations" due to the Russia-Ukraine conflict and the ensuing restrictive Measures.

“Semperit Group expects material bottlenecks as well as significant price increases for raw materials, intermediate goods, energy and transport services,” said the Vienna group in an ad-hoc statement 9 March.

“In addition, geopolitical and market-related developments will possibly lead to frictions in production at the European sites and subsequently to delivery delays and constraints,” it added.

Against this background, the group said it anticipates earnings (EBITDA) to come in at around €100-€120 million, considerably below the levels of 2021.

The group said it could not provide an exact estimate of the financial impact of the conflict on its results presently.

In a separate statement to ERJ on 9 March, Semperit said it has neither a production site nor operations in the Russian/Ukrainian region.

Individual sales employees who were on the ground immediately left for a safe country after the situation came to a head, a company spokeswoman told ERJ.

Semperit AG Holding’s result for 2021 will be published at the end of March, when the group is expected to deliver record-level figures.

The group announced in November last year that over the first nine months of 2021 posted record earnings at €324 million, up 174% compared to the same period last year.

Overall nine-month sales rose 41% year-on-year to €926 million, reflecting a 79% increase in medical sales to €517 million and an 11% rise in industrial sales to €409 million.